Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 53 (9), 2521-3

RDW as an Additional Marker in Inflammatory Bowel Disease/Undifferentiated Colitis

Affiliations

RDW as an Additional Marker in Inflammatory Bowel Disease/Undifferentiated Colitis

Kofi Clarke et al. Dig Dis Sci.

Abstract

Background: Anemia is a common complication in inflammatory bowel disease patients. We postulate that the distribution of lesions in Crohn's disease is more likely than ulcerative colitis to lead to malabsorption as an additional cause of anemia. RDW, a simple and inexpensive test could be an additional differentiating test.

Methods and results: Retrospective review of 284 cases of which 156 cases were diagnosed with Crohn's disease and 128 cases were diagnosed with ulcerative colitis. There was a significant difference in the mean RDW between the Crohn's and the ulcerative colitis cases (14.9 vs. 14.3, P = .027).

Conclusions: We conclude there is a statistical significance between the two groups though this may not represent a clinically significant difference. From our analysis we conclude that RDW is statistically significant and with the implementation of a more rigorous study design and analysis of further data RDW may prove to be a clinically effective marker in differentiating Crohn's disease from ulcerative colitis.

Comment in

Similar articles

See all similar articles

Cited by 15 PubMed Central articles

See all "Cited by" articles

References

    1. Am J Med. 2004 Apr 5;116 Suppl 7A:44S-49S - PubMed
    1. N Engl J Med. 2002 Aug 8;347(6):417-29 - PubMed
    1. Clin Microbiol Rev. 2002 Jan;15(1):79-94 - PubMed
    1. Am J Gastroenterol. 2001 Aug;96(8):2296-8 - PubMed
    1. Am J Gastroenterol. 2004 Nov;99(11):2235-41 - PubMed

MeSH terms

LinkOut - more resources

Feedback